EMEA-000816-PIP02-10-M03
Key facts
Invented name |
Izinova (and associated names)
|
Active substance |
|
Therapeutic area |
Gastroentology-Hepatology
|
Decision number |
P/0159/2022
|
PIP number |
EMEA-000816-PIP02-10-M03
|
Pharmaceutical form(s) |
Concentrate for oral solution
|
Condition(s) / indication(s) |
Diagnostic of organic and/or functional bowel diseases
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
IPSEN Consumer Healthcare
Email: ch_ra@ipsen.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|